1. Volume 139, Issue 4, Pages 1257-1266 (October 2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 1 
Stefan Zeuzem, Mark S. Sulkowski, Eric J. Lawitz, Vinod K. Rustgi, Maribel Rodriguez–Torres, Bruce R. Bacon, Mircea Grigorescu, Alan D. Tice, Yoav Lurie, Janusz Cianciara, Andrew J. Muir, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian, John G. McHutchison 
Gastroenterology 
Volume 139, Issue 4, Pages (October 2010)
DOI: /j.gastro
Copyright © 2010 AGA Institute Terms and Conditions

2. Figure 1
Summary of patient disposition and completion of treatment. albIFN, albinterferon alfa-2b; EVR12, early virologic response at week 12; HCV, hepatitis C virus; Peg-IFNα-2a, pegylated interferon-α-2a.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions

3. Figure 2
Intention-to-treat analysis of virologic response. (A) Rates of sustained virologic response (SVR), defined as hepatitis C virus (HCV) RNA <15 IU/mL at week 72. (B) Rates of HCV RNA <15 IU/mL during treatment (weeks 4, 12, 24, and 48) and rates of relapse (proportion of patients with HCV RNA < 15 IU/mL at week 48 who failed to achieve SVR). albIFN, albinterferon alfa-2b; Peg-IFNα-2a, pegylated interferon-α-2a.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions

4. Figure 3
Predictors of sustained virologic response by multivariate regression model. Multivariate logistic regression model–based adjusted odds ratios and associated 95% confidence intervals (CIs) for factors provided along the y-axis. Plotting symbol represents odds ratio and horizontal line spans coverage of CI. Vertical reference line at 1 indicates no difference. albIFN, albinterferon alfa-2b; ALT, alanine aminotransferase; F, fibrosis score; GGT, γ-glutamyl transpeptidase; HCV, hepatitis C virus; Peg-IFNα-2a, pegylated interferon-α-2a; ULN, upper limit of normal.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2010 AGA Institute Terms and Conditions